by James Hubbard, M.D., M.P.H.

An article in the September 10, 2007, Archives of Internal Medicine notes an almost three-fold increase in the number of serious adverse drug events during the years of 1998 to 2005 reported to the U.S. Food and Drug Administration. A serious outcome is defined as death (17.3%), life-threatening, disability, birth defect and outcomes that require hospitalizations or interventions. (more…)